DECIFER: Depression and Citalopram In First Episode Recovery
Status:
Completed
Trial end date:
2018-03-26
Target enrollment:
Participant gender:
Summary
This study seeks to examine the effectiveness of citalopram added to treatment with any oral
or injectable second-generation antipsychotic plus standardized psychoeducation in first
episode schizophrenia patients. Because depressive symptoms are common in first episode
patients, we will test the hypothesis that adding the SSRI citalopram to a pre-established
medication regimen will improve quality of life and decrease relapse and suicidality over the
course of a 12-month trial.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health